omega-Aminohexanoic acid · Eaca kabi · Acido aminocaproico · Acidum aminocaproicum · epsilon-Amino-n-hexanoic acid · Epsilon-aminocapronzuur. 6-aminohexanoic acid; 6-Aminocaproic acid; aminocaproic acid Source: Therapeutic Target Database (TTD) (D0FD0H) Deposit Date: Available. 6-Aminocaproic acid; 6-aminohexanoic acid; Acide aminocaproïque. Ácido aminocapróico. acidum aminocaproicum. Aminocaproic Acid; Aminocapronsäure .
|Published (Last):||16 August 2017|
|PDF File Size:||3.67 Mb|
|ePub File Size:||5.50 Mb|
|Price:||Free* [*Free Regsitration Required]|
This consequently will reduce the amount of bleeding post surgery. An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
Identification of sequences in apolipoprotein a that maintain its closed conformation: Tranexamic acid Tranexamic Acid may increase the thrombogenic activities of Aminocaproic Acid. Aminocaproic Acid Targets 3 Enzymes 1 Biointeractions 3. DrugBank does not sell nor buy drugs. Absorbed rapidly following oral administration. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Further information Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. A cyclic imine intermediate in the in vitro metabolic conversion of 1,6-diaminohexane to 6-aminohexanoic aminocaproco and caprolactam. Emicizumab Aminocaproic Scido may increase the thrombogenic activities of Emicizumab. Andexanet alfa Aminocaproic Acid may increase the thrombogenic activities of Andexanet alfa. How many drug targets are there?
Anti-inhibitor coagulant complex Aminocaproic Acid may increase the thrombogenic activities of Anti-inhibitor coagulant complex. Frantisek Mares, “Process for producing caprolactam amonocaproico 6-aminocaproic acid.
Acido Aminocaproico [DCIT,Spanish]
Unsourced material may be challenged and removed. Rockville, MD; Jul. General Function Serine-type endopeptidase activity Specific Function Converts the abundant, but inactive, zymogen plasminogen to plasmin by hydrolyzing a single Arg-Val bond in plasminogen. Aminocaproic Acid is reported as an ingredient of Acido Aminocaproico in the following countries:. Subscribe to receive email notifications whenever zminocaproico articles are published.
Subscribe to free Drugs. Inhibits tissue-type plasminogen activator 1. Turoctocog alfa Aminocaproic Acid may increase the thrombogenic activities of Turoctocog alfa. Etamsylate Carbazochrome Batroxobin thrombopoietin receptor agonist Aminlcaproico Avatrombopag Eltrombopag Lusutrombopag.
For this reason it is effective in treatment of certain bleeding disordersand it is marketed as Amicar. Beroctocog alfa Aminocaproic Acid may increase the thrombogenic activities of Beroctocog alfa. Vatreptacog alfa Aminocaproic Acid may increase the thrombogenic activities of Vatreptacog alfa. Phytomenadione K 1 Acid K 3.
The mean lag time in absorption is 10 minutes. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.
Views Read Edit View history. Effect of a synthetic carboxy-terminal peptide of alpha 2 -antiplasmin on urokinase-induced fibrinolysis.
The blockage of the high-affinity lysine binding sites of plasminogen by EACA significantly inhibits prourokinase-induced plasminogen activation. Aminocaproic acid works as an antifibrinolytic. Trenonacog alfa Aminocaproic Acid may increase the thrombogenic activities of Trenonacog alfa.
Drug created on June 13, Hydrogen peroxide Aminocaproic Acid may increase the thrombogenic activities of Hydrogen peroxide. This means it is still under development and may contain inaccuracies.